Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 24, 2018

View Archived Issues

Gilteritinib granted orphan designation in Europe for treatment of AML

Tmunity announces closing of series A financing

Inhibitors of ATP1A4 may be novel agents for male contraception

Swissmedic accepts filing for edaravone as treatment for ALS

Skyhawk Therapeutics announces launch with USD 8 million in seed funding

Domainex wins award to develop screening method for GPCRs

Astellas completes Mitobridge acquisition

LifeArc enters partnership to identify new drug targets with machine-learning, bioinformatics

New mu-opioid receptor/CACNA2D1 ligands identified at Laboratorios del Dr. Esteve

Roche discovers novel HBsAg and HBV DNA production inhibitors

Glaceum describes novel glucose-lowering agents

FDA approves IND for Traumakine for ARDS

Evofem initiates phase IIb/III study of Amphora to prevent chlamydia and gonorrhea infections

University of California, Oakland patents HPV16 E5 gene-specific siRNA

Novel HPV vaccines synthesized at Deutsches Krebsforschungszentrum

Margetuximab awarded fast track designation for metastatic HER-positive breast cancer

Tie1 targeting shown to reduce tumor metastasis and growth

CARB-X seeks new accelerator organizations

NIH launches Somatic Cell Genome Editing program

Inclisiran receives FDA orphan designation for homozygous familial hypercholesterolemia

BioMarck Pharmaceuticals starts phase II trial of BIO-11006

Qiagen's ipsogen JAK2 assay cleared by FDA

EMA committee communicates negative trend vote to Puma for neratinib MAA

FDA clears BioAtla's IND for BA-3011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...